Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5395-5404
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5395
Figure 1 Selection personalized peptide from the peptide candidate library by peptide-specific IFN-γ production assay in consideration of the pre-existing host immunity.
aP < 0.05, bP < 0.01.
- Citation: Shen J, Wang LF, Zou ZY, Kong WW, Yan J, Meng FY, Chen FJ, Du J, Shao J, Xu QP, Ren HZ, Li RT, Wei J, Qian XP, Liu BR. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(29): 5395-5404
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5395.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5395